Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday newspaper round-up: Ireland, General Motors, GlaxoSmithKline

Thu, 18th Nov 2010 06:31

The Irish Government finally signalled yesterday that it may bow to international pressure and accept a multibillion-pound bailout, amid divisions in the Commons over whether Britain should contribute. While the details of any package may be several days away, there were growing signs that Britain could play a prominent role in any rescue, the Times reports.According to the Telegraph, a squad of inspectors from the EU and the International Monetary Fund will arrive in Dublin on Thursday to go through the books of the Irish banking system and prepare the way for a likely rescue of at least €80bn (£68bn). Olli Rehn, Europe's economics commissioner, said Ireland is not strong enough to back-stop a banking system that has been shut out of capital markets and suffered a haemorrhage of bank deposits.With the unemployment rate still above 13% and remaining high, many with a bankable trade are now considering taking the drastic option of leaving Ireland in search of work, the Independent adds. The government expects as many as 100,000 people to leave over the next four years.General Motors could raise almost $23bn (£14.5m) in the largest flotation in history when it rejoins the public market today. The carmaker said yesterday that it had increased the number of common shares it would sell from 365m to 478m, 412 million of which would come from the US Government. GlaxoSmithKline is close to securing formal US approval for the first new drug in 50 years to treat the complex autoimmune disease lupus, after experts recommended the release of the treatment despite broad safety concerns. The drug, known as Benlysta, is one of the most important new drugs in Glaxo's pipeline, says the Guardian. Britain's electricity market is braced for its biggest shake-up since privatisation as the Government prepares to unveil a package of measures designed to shore up £200 billion worth of investment in greener sources of energy over the next decade. The Times has learnt that David Cameron discussed the proposed changes on Monday with officials from the Treasury, the Department for Energy and Climate Change and Chris Huhne, the Energy Secretary.Business investment is bouncing back, according to the Bank of England, offering proof that the Government's private-sector led recovery is starting to bear fruit, the Telegraph reports. The Bank's November business conditions survey found that "investment plans over the next twelve months were more positive than outturns had been over the past twelve months", and that many companies "were gradually increasing capital spending". A multi-million pound investigation by the Office of Fair Trading into allegations of price fixing in the supermarket sector has been pulled in the latest blow to the embattled regulator, the Daily Telegraph says. The investigation has been quietly shelved after the Office of Fair Trading (OFT) failed to find sufficient evidence of wrongdoing. The OFT raided a number of supermarkets and consumer goods companies in April 2008 after receiving information suggesting possible price collusion. Dawn raids were launched at Tesco, Asda, Sainsbury's and Morrisons.Asda's plans to leapfrog Tesco to become the UK's biggest general merchandise retailer appear to be stalling after it admitted that it is set to open only two new Asda Living non-food stores in 2011. After unveiling just two shops this year, the Walmart-owned supermarket chain now has 25 Asda Living stores, which sell products such as its George clothing brand and homewares, the Independent says.BP's board will tighten its oversight of the company's day-to-day operations in the wake of the Gulf of Mexico oil spill, its chairman has said in his first big interview since the accident. Carl-Henric Svanberg, app­oint­ed chairman in January, said he did not consider resigning following the oil spill in April, in spite of criticism from some investors for not taking a more public role at the height of the crisis, the FT reports.
More News
16 Jun 2023 17:01

LONDON MARKET CLOSE: FTSE 100 ends a week of rate decisions higher

(Alliance News) - Stocks in London ended largely higher on Friday, following a busy week centred on the interest rate decisions of three major central banks.

Read more
16 Jun 2023 11:59

GSK cancer drug delay by FDA not "necessarily a red flag"

(Alliance News) - GSK PLC must gain approval for its "centrepiece" cancer drug momelotinib to validate its mergers & acquisitions pipeline but the extension of its review period in the US does not automatically spell trouble, according to analysis from Shore Capital on Friday.

Read more
16 Jun 2023 07:47

FDA extends review period of GSK blood cancer drug momelotinib

(Sharecast News) - GSK said on Friday that the US Food and Drug Administration has extended the review period of its new drug application for momelotinib, which is used to treat a blood cancer called myelofibrosis.

Read more
16 Jun 2023 07:42

IN BRIEF: GSK says FDA extending review period for blood cancer drug

GSK PLC - Brentford, England-based pharmaceutical company - Says US Food & Drug Administration has extended the review period of the new drug application for momelotinib by three months. Extension aims to provide time to review recently submitted data. The extended action date is September 16. Momelotinib uses "novel mechanism of action" to treat myelofibrosis, a rare blood cancer, as well as progressive anaemia which characterises the disease. Myelofibrosis affects approximately 25,000 US patients. The drug is not currently approved in any markets. GSK says it is "confident in the momelotinib NDA and looks forward to working with the FDA as they finalise their review."

Read more
9 Jun 2023 06:53

AstraZeneca hails RSV drug nirsevimab recommendation by FDA committee

(Alliance News) - AstraZeneca PLC on Thursday said that a US Food & Drug Administration committee unanimously recommended its antibody nirsevimab.

Read more
8 Jun 2023 12:09

London "still attractive" place to list, as IPO activity trickles back

(Alliance News) - A recent revival of initial public offerings in London's equity markets is encouraging evidence that the city still holds appeal on the global stage, analysts contended.

Read more
7 Jun 2023 09:22

EU approves its first vaccine for common respiratory virus RSV

June 7 (Reuters) - European regulators have approved the region's first vaccine for respiratory syncytial virus (RSV), which causes thousands of hospitalisations and deaths annually.

Read more
7 Jun 2023 09:10

LONDON MARKET OPEN: Stocks head lower amid global growth fears

(Alliance News) - Stock prices in London opened in the red on Wednesday, as concerns about interest rate hikes and a global economic slowdown damped risk appetite.

Read more
7 Jun 2023 07:59

TOP NEWS: GSK's Arexvy is first EU-approved RSV jab for older adults

(Alliance News) - GSK PLC on Wednesday announced that its RSV vaccine Arexvy has become the first EU-backed vaccine against the respiratory syncytial virus for adults aged 60 and older.

Read more
7 Jun 2023 07:34

GSK gets European approval for RSV vaccine

(Sharecast News) - Pharmaceuticals giant GSK announced on Wednesday that the European Commission has granted authorisation for 'Arexvy' - an adjuvant respiratory syncytial virus (RSV) vaccine - for active immunisation to prevent RSV-caused lower respiratory tract disease (LRTD) in adults 60 and older.

Read more
6 Jun 2023 08:34

US FDA accepts GSK's licence application for cancer treatment Jemperli

(Alliance News) - GSK PLC on Tuesday said the US Food & Drug Administration accepted its supplemental biologics licence application for endometrial cancer treatment dostarlimab, or Jemperli, after it was granted priority review in September.

Read more
6 Jun 2023 07:41

PRESS: Unilever starts search to replace Nils Andersen as chair

(Alliance News) - Unilever PLC has appointed executive search firm Spencer Stuart to find a replacement for Chair Nils Andersen, Bloomberg reported on Monday, citing "people familiar with the situation".

Read more
6 Jun 2023 07:18

US FDA accepts GSK supplemental application for Jemperli cancer drug

(Sharecast News) - GSK said the US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application for its Jemperli treatment of adults with primary advanced or recurrent endometrial cancer.

Read more
2 Jun 2023 21:42

IN THE KNOW: hVIVO involvement in drug approval should boost interest

(Alliance News) - hVIVO's involvement in the approval of pharmaceutical giant Pfizer's new vaccine Abrysvo should support interest in its services, according to Liberum.

Read more
31 May 2023 23:35

US FDA approves Pfizer's RSV vaccine

May 31 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot against the common respiratory disease that can be fatal for seniors.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.